(RGA) Reinsurance of America - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7593516047
RGA: Life, Health, Insurance, Reinsurance, Annuities, Investments
Reinsurance Group of America (RGA) is a leading global reinsurer, playing a crucial role in the insurance ecosystem by managing risk for life and health insurers. They offer a diverse array of products, including term life, whole life, and group life and health insurance, addressing both individual and group needs. Their expertise extends to critical illness, disability, and longevity products, which are vital for insurers seeking to mitigate long-term risks. RGAs role is fundamental in the insurance industry, enabling primary insurers to stabilize their risk exposure and enhance their capital management.
With operations spanning across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific, RGAs global footprint is a testament to their strategic diversification and market reach. This extensive presence allows them to navigate varying regulatory environments and capitalize on emerging market opportunities, which is advantageous for their risk management strategies and operational resilience.
From a financial standpoint, RGAs market capitalization stands at $15.18 billion, with a trailing P/E ratio of 21.47 and a forward P/E of 8.76, indicating expectations of future earnings growth. Their price-to-book ratio is 1.27, reflecting a modest premium over book value, while the price-to-sales ratio of 0.69 suggests a reasonable valuation relative to their revenue. These metrics provide investors with a clear picture of the companys financial health and valuation metrics.
RGAs commitment to innovation is evident through their technology solutions, which streamline operations and enhance decision-making for their clients. Additionally, their consulting and outsourcing services position them as a comprehensive partner to insurers, offering not just risk management but also operational efficiency. This dual approach of traditional reinsurance and modern technological solutions underscores RGAs strategic evolution and market leadership.
Additional Sources for RGA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RGA Stock Overview
Market Cap in USD | 13,382m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception | 1993-05-04 |
RGA Stock Ratings
Growth 5y | 77.5% |
Fundamental | 44.6% |
Dividend | 60.6% |
Rel. Strength Industry | -12.6 |
Analysts | 4.17/5 |
Fair Price Momentum | 182.36 USD |
Fair Price DCF | 3279.30 USD |
RGA Dividends
Dividend Yield 12m | 1.78% |
Yield on Cost 5y | 4.10% |
Annual Growth 5y | 4.44% |
Payout Consistency | 99.3% |
RGA Growth Ratios
Growth Correlation 3m | -45.2% |
Growth Correlation 12m | 54% |
Growth Correlation 5y | 93.8% |
CAGR 5y | 16.89% |
CAGR/Max DD 5y | 0.42 |
Sharpe Ratio 12m | 1.68 |
Alpha | -4.05 |
Beta | 0.63 |
Volatility | 31.58% |
Current Volume | 793k |
Average Volume 20d | 557.7k |
As of March 12, 2025, the stock is trading at USD 187.27 with a total of 792,977 shares traded.
Over the past week, the price has changed by -2.99%, over one month by -4.34%, over three months by -10.60% and over the past year by +3.88%.
Partly, yes. Based on ValueRay Fundamental Analyses, Reinsurance of America (NYSE:RGA) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 44.62 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGA as of March 2025 is 182.36. This means that RGA is currently overvalued and has a potential downside of -2.62%.
Reinsurance of America has received a consensus analysts rating of 4.17. Therefor, it is recommend to buy RGA.
- Strong Buy: 5
- Buy: 4
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, RGA Reinsurance of America will be worth about 202 in March 2026. The stock is currently trading at 187.27. This means that the stock has a potential upside of +7.88%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 252.7 | 35% |
Analysts Target Price | 255.3 | 36.3% |
ValueRay Target Price | 202 | 7.9% |